We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Atlantic Lithium Limited | LSE:ALL | London | Ordinary Share | AU0000237554 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.55 | -2.69% | 19.90 | 19.92 | 20.20 | 20.50 | 19.96 | 20.50 | 624,170 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Iron Ores | 0 | -12.19M | -0.0200 | -9.98 | 121.6M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2012 08:06 | Brilliant set of results this morning for Allocate software - smashing expectations. Dividends start flowing and fascinating new acquisition of patient flow management system. Is this the most undervalued company in the FTSE? | king_roster_iii | |
24/2/2012 12:33 | Interesting ALLOCATE SOFTWARE was 74p when this was published: now it's 87p..still more upside according to brokers. company makes more money when economy in trouble..jobless 3mln..oh boy are we in trouble. | ipoman2 | |
07/2/2012 10:52 | Staff rostering specialist Allocate Software (LON:ALL) said today underlying revenues grew in its latest half-year as momentum continued to build in its core NHS market. Revenues overall rose to £16 million from £15.9 million in the half year to November, with underlying sales up by 15% excluding acquisitions and a £3 million contract in Australia in the previous year. | lucky_punter | |
09/1/2012 13:07 | Allocate Software - Healthy start Click for report 1:05 PM | texas tea | |
25/11/2011 09:42 | Ageing populations, growing demand for treatment and cuts to healthcare budgets are problems that face hospitals all across the developed world. The pressure is providing an opportunity for IT companies specialising in the health arena such as staff rostering specialist Allocate Software (LON:ALL). | lucky_punter | |
11/11/2011 07:39 | From todays SEC announcement The key positive contributors to performance in the period were Allocate, Vintage and Pinewood, which rose 4%, 11% and 2% respectively. Allocate released final results ahead of expectations and forecasts were upgraded. Although this has been a successful investment so far for the SEC, we believe that the considerable progress made over the past two years has failed to be fully reflected in its share price. Since May, we have increased our holding by about 45%. Vintage's movement was a result of the strong performance in its highly diversified private equity portfolios. | the shuffle man | |
06/9/2011 12:50 | Looks like a good set of final figures with an encouraging statement. Be interested to see the semi official "analysts forecasts" for the current year. Only grouse I ever have, although it applies to almost every acquisitive company, is when advisers consider it almost mandatory to include in the official acquisitive documents the statement that "in terms of eps the acquisition will be enhancing in the first year". However then there seems to be a drag on earnings in the second year!It's just a general grouse. Pity about the share price but it is a bear market however short-or long! | gregmorg | |
15/7/2011 10:56 | Interview with Ian Bowles - | rockafella2 | |
31/3/2011 09:15 | Thanks n1blet. There was a fortnightly magazine called Techmark years ago(when I was alive!) and it was very authoritative. The one you refer to is from a new organisation according to its site and which appears to aim to be precisely that. Not quite what I expected when you referred to analysts which I had assumed referred to "sell side". Still all comment spreads the word and the more write ups the better!. | gregmorg | |
30/3/2011 02:16 | gregmorg they are, followers of the whole IT world:- Techmarketview | n1blet | |
23/3/2011 10:44 | n1blet. Purely for my added information what analyst comment are you referring to?Numis is the shop whilst Edison is a paid research house. If there are others researching the stock as well then that would be excellent in terms of spreading the word as this tiddler grows.I await your reponse. | gregmorg | |
22/3/2011 23:49 | analyst comment, that they are def producing what the NHS needs, to achieve cost saving, but with the abolition of PHT's & setting up of GP consortia's, there is some hiatus amongst the signers off of contracts, whilst contract growth is running despite all this at 30%pa. + overall inotherwards, Not read rec above yet, but looks to still be very low profile as a business. | n1blet | |
22/3/2011 10:59 | Yesterday's 3rd qtr update was fine other than reading between the lines there seemed a touch of caution re timing of contracts being signed off. Whether that is the forerunner of something else is at this stage unknown but it obviously has caused a little concern. It seems that recent momentum has slowed but given the background that is hardly surprising.Still, fingers crossed for the longer term! | gregmorg | |
01/3/2011 16:51 | GCI recommendation by analyst Ben Jaglom | akhtar8 | |
23/2/2011 09:50 | Yes a nice thing to see. A new non exec buying a decent chunk of shares is quite a rare thing these days. For very obvious reasons I hope he makes a very large profit! This so makes a change to the usual PLC director stance these days of claiming to be on the side of shareholders yet all they have done is to benefit from very generous executive option schemes whilst also being over paid. Nice to see someone "putting his money etc". | gregmorg | |
23/2/2011 08:28 | A decent initial purchase of 50,000 shares by Richard King... ZZZ | zorija | |
13/2/2011 11:31 | Thanks Aim_Trader a very informative video that I've now added to the header. | jakleeds | |
13/2/2011 10:52 | Ian Bowles of Allocate Software says he's confident Allocate will continue to grow turnover Friday, February 11, 2011 Ian Bowles, Chief Executive of Allocate Software, tells Proactive Investors that he confident that Allocate can sustain growth over the next 2-3 years. Ian says though that the difficulty encountered by Dynamic Change (healthcare sector), with the Primary Care Trusts being dismantled, can be overcome for two reaso | aim_trader | |
11/2/2011 09:28 | thanks greg I stand corrected! | littleweed | |
10/2/2011 10:54 | Not that it matters but I don't actually think this is an all time high for the share price! That may surprise most investors but it was floated on the full market as MSW(before changing its name to Manpower etc) in the mid 1990's. The price then that I recall was something like 97p. However it was a painful experience and a real disaster. Fortunately it was recued and more than once but it survived. One executive and one non exec survive from that horrible period. Anyway it's a completely different animal now and one that has become quite pleasing with maybe even more pleasure to come. Purely a trip down memory lane! | gregmorg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions